Clinical Trials List
2023-10-01 - 2026-12-31
Phase III
Not yet recruiting4
Recruiting5
ICD-10I97.3
Postprocedural hypertension
ICD-9997.91
Complications affecting other specified body system, not elsewhere classified, hypertension
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Po-Chao Hsu Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- 卓士傑 Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 吳宏彬 Division of Cardiovascular Diseases
- 林晏年 Division of Cardiovascular Diseases
- 王宇澄 Division of Cardiovascular Diseases
- Lien-Cheng Hsiao Division of Cardiovascular Diseases
- 陳恬恩 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 周銘霆 Division of Cardiovascular Diseases
- 施志遠 Division of Cardiovascular Diseases
- Chia-Te Liao Division of Cardiovascular Diseases
- Zhih-Cherng Chen Division of Cardiovascular Diseases
- 黃柏森 Division of Cardiovascular Diseases
- 林志憲 Division of Cardiovascular Diseases
- 張瑋婷 Division of Cardiovascular Diseases
- 黃聖中 Division of Cardiovascular Diseases
- 蔣俊彥 Division of Cardiovascular Diseases
- 李威杰 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- - - Division of Nephrology
- 賀立婷 Division of Cardiovascular Diseases
- 黃道民 Division of Nephrology
- Hsien Li Kao Division of Cardiovascular Diseases
- 洪啟盛 無
- 林柏志 無
- 蔡承烜 Division of Cardiovascular Diseases
- HUNG-JU LIN 無
- JEN-KUANG LEE Division of Cardiovascular Diseases
- CHO-KAI WU Division of Cardiovascular Diseases
- VIN-CENT Wu 無
- Chih-Fan Yeh 無
- Tzung-Dau Wang Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳志維 Division of Cardiovascular Diseases
- Chun-Ming Shih Division of Cardiovascular Diseases
- Tsung-Lin Yang Division of Cardiovascular Diseases
- Chien-Yi Hsu Division of Cardiovascular Diseases
- 蕭卜源 Division of Cardiovascular Diseases
- Yung-Ta Kao Division of Cardiovascular Diseases
- 詹超舜 Division of Cardiovascular Diseases
- 鄭宇倫 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭泠 Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- Tse-Min Lu Division of Cardiovascular Diseases
- 李慶威 Division of Cardiovascular Diseases
- 吳承學 Division of Cardiovascular Diseases
- Chern-En Chiang 臨床試驗科
- 廖若男 Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
- 蔡依霖 Division of Cardiovascular Diseases
- 黃少嵩 Division of Cardiovascular Diseases
- Hao-min Cheng Division of Cardiovascular Diseases
- 張俊欽 Division of Cardiovascular Diseases
- Tze-Fan Chao Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
720 participants
